메뉴 건너뛰기




Volumn 21, Issue 10, 2011, Pages 715-717

The full cost and burden of disorders of the brain in Europe exposed for the first time

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DISEASE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG INDUSTRY; EDITORIAL; EUROPE; FUNDING; HEALTH CARE COST; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; PREVALENCE; PRIORITY JOURNAL;

EID: 80053549115     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2011.09.005     Document Type: Editorial
Times cited : (18)

References (6)
  • 4
    • 79959197550 scopus 로고    scopus 로고
    • ECNP summit in the future of CNS drug research in Europe
    • Nutt D.J., Goodwin G.M. ECNP summit in the future of CNS drug research in Europe. European Neuropsychopharmacology 2011, 21:495-499.
    • (2011) European Neuropsychopharmacology , vol.21 , pp. 495-499
    • Nutt, D.J.1    Goodwin, G.M.2
  • 5
    • 19844373148 scopus 로고    scopus 로고
    • Size and burden of mental disorders in Europe - a critical review and appraisal of 27 studies
    • Wittchen H.-U., Jacobi F. Size and burden of mental disorders in Europe - a critical review and appraisal of 27 studies. European Neuropsychopharmacology 2005, 15(4):357-376.
    • (2005) European Neuropsychopharmacology , vol.15 , Issue.4 , pp. 357-376
    • Wittchen, H.-U.1    Jacobi, F.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.